# Core D: Program Administration

> **NIH NIH P01** · DANA-FARBER CANCER INST · 2021 · $126,586

## Abstract

The Program Administration Core will facilitate the overall goals of the Program by providing administrative and
fiscal support as well as scientific oversight, to ensure that the activities of the Program are consistent with its
ultimate goal i.e. the development of new targeted therapies for non-small cell lung cancer. This involves
coordination of all Programmatic activities, in particular promoting collaboration, cross-talk and sharing of
information and ideas between the various Projects and Cores. This includes the assessment and
implementation of changes in research trajectory, as required, to ensure research progress and alignment of
activities with the overall goals of the program. This will be accomplished via the following Specific Aims:
Specific Aim 1: Monitor projects and shared resource cores and evaluate overall research progress.
a) Coordinate regular meetings of a Program Executive Committee, including each of the Project Leaders and
 Core Directors, to monitor the progress of each Project and Shared Resource Core.
b) Provide regular guidance to the Project Leaders and Core Directors, including critical evaluation of
 research progress and direction.
c) Obtain advice from an Internal Advisory Committee of scientists within Dana-Farber Cancer Institute, and
 monitor the integration of the committee’s suggestions into the performance of the Projects and Cores.
d) Hold meetings of an External Advisory Board of scientists with expertise in lung cancer targeted therapies.
Specific Aim 2: Foster collaboration and communication among the projects and shared resource cores.
a) Arrange bi-weekly group meetings of the Program to share research ideas, results, and methods.
b) Monitor and encourage the interactions between projects and cores.
Specific Aim 3: Provide fiscal oversight and support for the program.
a) Assist with grants management and disbursement of funds.
b) Analyze and adjust budgets to incorporate ongoing innovations and as the program evolves.
Specific Aim 4: Promote the clinical translation of diagnostic and therapeutic discoveries from the program.
a) Ensure that translatable discoveries are effectively communicated to the Dana-Farber/Harvard Cancer
 Center Lung Cancer Program.
b) Organize a retreat to disseminate the research findings and prompt synergistic interactions.
c) Assist in manuscript submission and subsequent publication.

## Key facts

- **NIH application ID:** 10231105
- **Project number:** 5P01CA154303-10
- **Recipient organization:** DANA-FARBER CANCER INST
- **Principal Investigator:** Matthew L. Meyerson
- **Activity code:** P01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $126,586
- **Award type:** 5
- **Project period:** 2012-05-11 → 2023-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10231105

## Citation

> US National Institutes of Health, RePORTER application 10231105, Core D: Program Administration (5P01CA154303-10). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10231105. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*